menu
    • menu

    Company profile for BridgeBio Pharma

    NEW Drugs in Dev: 17
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to find, develop, and deliver breakthrough medicines for genetic diseases to patients as quickly and safely as possible.We create a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. We are working to create a bridge between promising genetic research and actual medicines with the peop...
    Our mission is to find, develop, and deliver breakthrough medicines for genetic diseases to patients as quickly and safely as possible.We create a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. We are working to create a bridge between promising genetic research and actual medicines with the people, platform, and processes needed to advance multiple individual therapies simultaneously.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BridgeBio PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    421 Kipling Street, Palo Alto, CA 94301
    Telephone
    Telephone
    650-391-9740
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bridgebio.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/bridgebio
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/bridgebio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BridgeBio Submits Encaleret NDA to FDA for ADH1 Patients
    BridgeBio Submits Encaleret NDA to FDA for ADH1 Patients

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3292712/0/en/bridgebio-submits-nda-to-fda-for-encaleret-for-individuals-living-with-adh1.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Bridgebio Challenges Pfizer In ATTR-CM With Late-Stage Data
    Bridgebio Challenges Pfizer In ATTR-CM With Late-Stage Data

    12 May 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/bridgebio-stands-up-to-pfizer-in-attr-cm-as-late-stage-data-hint-at-better-survival

    BIOSPACE
    12 May 2026
    Share Share
    BridgeBio Pharma Issues Inducement Grants Under Nasdaq Rule
    BridgeBio Pharma Issues Inducement Grants Under Nasdaq Rule

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291319/0/en/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    BridgeBio Reports Q1 2026 Results and Corporate Updates
    BridgeBio Reports Q1 2026 Results and Corporate Updates

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3290504/0/en/bridgebio-reports-first-quarter-2026-financial-results-and-corporate-updates.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Bridgebio To Participate In May And June Investor Conferences
    Bridgebio To Participate In May And June Investor Conferences

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3289291/0/en/bridgebio-to-participate-in-may-and-june-investor-conferences.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share
    BridgeBio to Share Acoramidis Disease and Biomarker Data at ESC
    BridgeBio to Share Acoramidis Disease and Biomarker Data at ESC

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286590/0/en/bridgebio-to-present-new-acoramidis-data-on-disease-progression-biomarkers-and-clinical-outcomes-at-esc-heart-failure-2026.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search